Previous Research: Antipsychotic Drugs and Diabetes Research

Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, Kabir M, Bergman RN. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes. 2005;54(3);862-871. http://diabetes.diabetesjournals.org/content/54/3/862.full.

Ader M, Garvey WT, Phillips LS, Nemeroff CB, Gharabawi G, Mahmoud R, Greenspan A, Berry SA, Musselman DL, Morein J, et al. Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia. J Psychiatr Res. 2008;42(13):1076-1085. http://www.journalofpsychiatricresearch.com/article/S0022-3956(08)00006-X/fulltext.

Bergman RN, Ader M. Atypical antipsychotics and glucose homeostasis. J Clin Psychiatry. 2005;66(4):504-514. http://europepmc.org/abstract/med/15816794.

Gohlke JM, Dhurandhar EJ, Correll CU, Morrato EH, Newcomer JW, Remington G, Nasrallah HA, Crystal S, Nicol G; Adipogenic and Metabolic Effects of APDs Conference Speakers [including Ader M], et al. Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Front Psychiatry. 2012;3:62. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385013/.

Ader M, Stefanovski D, Kim SP, Richey JM, Ionut V, Catalano KJ, Hucking K, Ellmerer M, Van Citters G, Hsu IR, et al. Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity (Silver Spring). 2014;22(5):1238-1245. http://onlinelibrary.wiley.com/doi/10.1002/oby.20625/abstract.

Ader M, Stefanovski D, Richey JM, Kim SP, Kolka CM, Ionut V, Kabir M, Bergman RN. Failure of homeostatic model assessment of insulin resistance to detect marked diet-induced insulin resistance in dogs. Diabetes. 2014;63(6):1914-1919. http://diabetes.diabetesjournals.org/content/63/6/1914.abstract.

Bergman RN, Kim SP Catalano KJ, Hsu IR, Chiu, JD, Kabir M, Hucking K, Ader M. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring). 2006 Feb;14 Suppl 1:16S-19S. http://onlinelibrary.wiley.com/doi/10.1038/oby.2006.277/full.

Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med. 2007 Feb;120(2 Suppl 1):S3-S8; discussion S29-S32. http://www.amjmed.com/article/S0002-9343(06)01361-1/fulltext.

Hamilton-Wessler M, Ader M, Dea MK, Moore D, Loftager M, Markussen J, Bergman RN. Mode of transcapillary transport of insulin and insulin analog NN304 in dog hindlimb: evidence for passive diffusion. Diabetes. 2002;51(3):574-582. http://diabetes.diabetesjournals.org/content/51/3/574.

Ader M, Joyce M. Richey JM, Hucking K, Ionut V, Catalano KJ, Kim SP, Kabir M, Bergman RN. Oral glucose tolerance test fails to reveal substantial metabolic abnormalities induced by antipsychotic agents. Meeting: 66th Scientific Sessions (2006). Abstract Number: 1507-P. Category: Integrated Physiology - Regulation of Glucose Kinetics. http://professional.diabetes.org/abstract/oral-glucose-tolerance-test-fails-reveal-substantial-metabolic-abnormalities-induced.

Ader M, Catalano KJ, Ionut V, Kim SP, Hucking K, Richey JM, Kabir M, Bergman RN. Increased caloric intake explains weight gain with some, but not all, antipsychotic therapy. Meeting: 65th Scientific Sessions (2005). Abstract Number: 1848-P. Category: Obesity - Human.
http://professional.diabetes.org/abstract/increased-caloric-intake-explains-weight-gain-some-not-all-antipsychotic-therapy.


Back to research